Results 221 to 230 of about 31,515 (266)

Limitations of antifungal prophylaxis in preventing invasive <i>Candida</i> surgical site infections after liver transplant surgery. [PDF]

Antimicrob Agents Chemother
Carugati M, Arif S, Yarrington ME, King LY, Harris M, Evans K, Barbas AS, Sudan DL, Perfect JR, Miller RA, Alexander BD.   +10 more
europepmc   +1 more source

Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies. [PDF]

Hemasphere, 2022
europepmc   +1 more source

Pharmacoeconomics Evaluation of the Systemic Antifungal Posaconazole for Prophylaxis against Invasive Fungal Infections among Immunocompromised Cancer Patients in Qatar

, 2018
Wafa Ziad Al-Marridi
openalex   +1 more source

Influence of Antifungal Prophylaxis on Cyclophosphosphamide Based Regimen Transplant Outcomes

, 2014
D. Williams, Gabrielle Flash
openalex   +1 more source

Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit. [PDF]

Infection
Fumarola B, Signorini L, Lorenzotti S, Lanza P, Saccani B, Van Hauwermeiren E, Mulè A, Piva S, Rota M, Zuccalà F, Rasulo FA, Filippini M, Bertazzoli A, Del Fabro G, Matteelli A.   +14 more
europepmc   +1 more source